BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26391623)

  • 21. Intravenous Cavutilide for Pharmacological Conversion of Paroxysmal and Persistent Atrial Fibrillation in Patients with Heart Failure.
    Beliaeva MM; Dzaurova KM; Yuricheva YA; Novikov PS; Mironov NY; Tarasovskiy GS; Zelberg MA; Sokolov SF; Golitsyn SP
    J Cardiovasc Dev Dis; 2023 Dec; 10(12):. PubMed ID: 38132655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of azimilide for the maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation in the presence and absence of structural heart disease.
    Kerr CR; Connolly SJ; Kowey P; Page RL; Pritchett EL; Ruda MY; Ruzyllo W; Wilkinson WE;
    Am J Cardiol; 2006 Jul; 98(2):215-8. PubMed ID: 16828595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias.
    Shantsila E; Watson T; Lip GY
    Europace; 2007 Sep; 9 Suppl 4():iv37-44. PubMed ID: 17766322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiarrhythmic efficacy of azimilide in patients with atrial fibrillation. Maintenance of sinus rhythm after conversion to sinus rhythm.
    Pritchett EL; Kowey P; Connolly S; Page RL; Kerr C; Wilkinson WE;
    Am Heart J; 2006 May; 151(5):1043-9. PubMed ID: 16644334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Procedural arrhythmia termination and long-term single-procedure clinical outcome in patients with non-paroxysmal atrial fibrillation.
    Zhou G; Chen S; Chen G; Zhang F; Meng W; Yan Y; Lu X; Wei Y; Liu S
    J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1092-100. PubMed ID: 23790106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progression of paroxysmal atrial fibrillation to persistent atrial fibrillation in patients with bradyarrhythmias.
    Saksena S; Hettrick DA; Koehler JL; Grammatico A; Padeletti L
    Am Heart J; 2007 Nov; 154(5):884-92. PubMed ID: 17967594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical efficacy of dofetilide for the treatment of atrial tachyarrhythmias in adults with congenital heart disease.
    Banchs JE; Baquero GA; Nickolaus MJ; Wolbrette DL; Kelleman JJ; Samii S; Grando-Ting J; Penny-Peterson E; Davidson WR; Young SK; Naccarelli GV; Gonzalez MD
    Congenit Heart Dis; 2014; 9(3):221-7. PubMed ID: 23947935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Conversion rate and prevention of recurrence of paroxysmal and sustained atrial fibrillation or atrial flutter with verapamil/quinidine].
    Trappe HJ; Pfitzner P
    Med Klin (Munich); 1996 Oct; 91(10):617-25. PubMed ID: 9019638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Five-year follow-up after catheter ablation of persistent atrial fibrillation using the stepwise approach and prognostic factors for success.
    Schreiber D; Rostock T; Fröhlich M; Sultan A; Servatius H; Hoffmann BA; Lüker J; Berner I; Schäffer B; Wegscheider K; Lezius S; Willems S; Steven D
    Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):308-17. PubMed ID: 25744570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A mutation in the sodium channel is responsible for the association of long QT syndrome and familial atrial fibrillation.
    Benito B; Brugada R; Perich RM; Lizotte E; Cinca J; Mont L; Berruezo A; Tolosana JM; Freixa X; Brugada P; Brugada J
    Heart Rhythm; 2008 Oct; 5(10):1434-40. PubMed ID: 18929331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety considerations in the pharmacological management of atrial fibrillation.
    Camm AJ
    Int J Cardiol; 2008 Jul; 127(3):299-306. PubMed ID: 18191470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of sequential antiarrhythmic treatment in sinus rhythm maintenance after successful electrocardioversion in patients with chronic non-valvular atrial fibrillation.
    Kosior D; Opolski G; Torbicki A
    Med Sci Monit; 2001; 7(1):68-73. PubMed ID: 11208496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program Substudy.
    Singh SN; Tang XC; Singh BN; Dorian P; Reda DJ; Harris CL; Fletcher RD; Sharma SC; Atwood JE; Jacobson AK; Lewis HD; Lopez B; Raisch DW; Ezekowitz MD;
    J Am Coll Cardiol; 2006 Aug; 48(4):721-30. PubMed ID: 16904540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent heart rate history affects QT interval duration in atrial fibrillation.
    Riad FS; Razak E; Saba S; Shalaby A; Nemec J
    PLoS One; 2017; 12(3):e0172962. PubMed ID: 28273109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Marine n-3 fatty acids, atrial fibrillation and QT interval in haemodialysis patients.
    Kirkegaard E; Svensson M; Strandhave C; Schmidt EB; Jørgensen KA; Christensen JH
    Br J Nutr; 2012 Mar; 107(6):903-9. PubMed ID: 21791142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New facts about pathogenesis of atrial fibrillation: correlation between changes in bioelectric brain activity and recurrence of atrial fibrillation paroxysms].
    Nedostup AV; Vasiukov SS; Fedorova VI; Gordeev SA
    Ter Arkh; 2007; 79(9):38-45. PubMed ID: 18038585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Termination of long-lasting persistent versus short-lasting persistent and paroxysmal atrial fibrillation by ablation.
    Fiala M; Chovancík J; Nevralová R; Neuwirth R; Jiravský O; Januska J; Branny M
    Pacing Clin Electrophysiol; 2008 Aug; 31(8):985-97. PubMed ID: 18684255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pacing or ablation: which is better for paroxysmal atrial fibrillation-related tachycardia-bradycardia syndrome?
    Chen YW; Bai R; Lin T; Salim M; Sang CH; Long DY; Yu RH; Tang RB; Guo XY; Yan XL; Nie JG; Du X; Dong JZ; Ma CS
    Pacing Clin Electrophysiol; 2014 Apr; 37(4):403-11. PubMed ID: 24456243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of good responders to rhythm control of paroxysmal and persistent atrial fibrillation by transthoracic and transesophageal echocardiography.
    Wang YC; Lin LC; Lin MS; Lai LP; Hwang JJ; Tseng YZ; Tseng CD; Lin JL
    Cardiology; 2005; 104(4):202-9. PubMed ID: 16155395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation.
    Roy D; Rowe BH; Stiell IG; Coutu B; Ip JH; Phaneuf D; Lee J; Vidaillet H; Dickinson G; Grant S; Ezrin AM; Beatch GN;
    J Am Coll Cardiol; 2004 Dec; 44(12):2355-61. PubMed ID: 15607398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.